Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
18.07
+0.17 (+0.95%)
Streaming Delayed Price
Updated: 12:52 PM EST, Dec 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
August 09, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
88 Biggest Movers From Yesterday
August 05, 2021
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...
Via
Benzinga
99 Biggest Movers From Yesterday
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
Understanding Arcturus Therapeutics's Unusual Options Activity
August 03, 2021
On Tuesday, shares of Arcturus Therapeutics (NASDAQ:ARCT)...
Via
Benzinga
75 Biggest Movers From Yesterday
August 04, 2021
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a...
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge
August 03, 2021
Toward the end of trading Tuesday, the Dow traded up 0.64% to 35,059.40 while the NASDAQ rose 0.34% to 14,731.57. The S&P also rose, gaining 0.65% to 4,415.65. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 03, 2021
Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's...
Via
Benzinga
Mid-Day Market Update: Crude Oil Down 2%; Arcturus Therapeutics Shares Spike Higher
August 03, 2021
Midway through trading Tuesday, the Dow traded up 0.11% to 34,878.06 while the NASDAQ fell 0.37% to 14,626.97. The S&P also fell, dropping 0.01% to 4,386.68. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Arcturus Therapeutics Stock Is Soaring Today
August 03, 2021
The company received a green light to advance two COVID-19 vaccine candidates into clinical testing in a second country.
Via
The Motley Fool
Exposures
COVID-19
21 Stocks Moving in Tuesday's Pre-Market Session
August 03, 2021
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares rose 46% to $6.35 in pre-market trading following Form 4 filing from the company’s 10% owner, Retail Ecommerce...
Via
Benzinga
48 Stocks Moving In Tuesday's Mid-Day Session
August 03, 2021
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures...
Via
Benzinga
Arcturus Announces Approval of Singapore Clinical Trial Application to Advance ARCT-154 and ARCT-165, Next Generation STARR™ mRNA Vaccines Targeting SARS-CoV-2 Variants of Concern, in a Phase 1/2 Study
August 03, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
August 02, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Arcturus' COVID-19 mRNA Vaccine Candidate To Target Variants, Trial To Start In Vietnam
August 02, 2021
The Vietnam Ministry of Health has signed off Arcturus Therapeutics Holdings Inc's (NASDAQ: ARCT) Clinical Trial Application (CTA) to advance ARCT-154 COVID19...
Via
Benzinga
Exposures
COVID-19
Arcturus Therapeutics Stock Jumps On Establishment Of COVID-19 Vaccine Plant In Vietnam
August 02, 2021
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) has collaborated with Vinbiocare to establish a manufacturing facility in Vietnam for its...
Via
Benzinga
Exposures
COVID-19
Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
August 02, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics Collaborates with Vingroup to Establish Manufacturing Facility in Vietnam for Arcturus’ Investigational mRNA Vaccines for COVID-19
August 02, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Announces Regulatory Approval to Proceed with Phase 2 Study of ARCT-810 mRNA Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency
July 28, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Report Second Quarter 2021 Financial Results and Provide Corporate Update on August 9, 2021
July 26, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
July 06, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 2, 2021
July 02, 2021
Upgrades According to Deutsche Bank, the prior rating for Encompass Health Corp (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 02, 2021
Gainers Alector (NASDAQ:ALEC) stock moved upwards by 39.93% to $31.36 during Friday's pre-market session. The market value of their outstanding shares is at $2.5...
Via
Benzinga
Return On Capital Employed Overview: Arcturus Therapeutics
June 24, 2021
During Q1, Arcturus Therapeutics's (NASDAQ:ARCT) reported sales totaled $2.13 million. Despite a 85.53% in earnings, the company posted a loss of $57.67 million. In Q4, Arcturus...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021
June 21, 2021
Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 21, 2021
Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5...
Via
Benzinga
10 Biggest Price Target Changes For Monday
June 21, 2021
SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...
Via
Benzinga
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
June 09, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Looking Into Arcturus Therapeutics's Return On Capital Employed
June 08, 2021
In Q1, Arcturus Therapeutics (NASDAQ:ARCT) posted sales of $2.13 million. Earnings were up 85.53%, but Arcturus Therapeutics still reported an overall loss of $57.67 million....
Via
Benzinga
High Flyers At Much Lower Altitudes
May 14, 2021
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.